TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MAZE

Maze Therapeutics, Inc.

Healthcare · Biotechnology · —

28.40$ +26.8% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MAZE
Line item 2022 2023 2024 2025
-100.0%
+7.0% -19.4% -27.1%
-101.4%
-16.2% +12.9% +29.9%
+7.8% +7.4% +30.4%
-11.2% +11.5% +27.8%
-348.1%
-345.5%
-351.0%
-327.0%

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?